Rate the Speakers - Paul Anderson, N.M.D. Please select your answer 10 9 8 7 6 5 4 3 2 1
Rate the Speakers - Jill Crista, N.D. Please select your answer 10 9 8 7 6 5 4 3 2 1
Rate the Speakers - Lauren Tessier, N.D. Please select your answer 10 9 8 7 6 5 4 3 2 1
Rate the Speakers - Mary Beth Ackerley, M.D., MD(H), ABIHM Please select your answer 10 9 8 7 6 5 4 3 2 1
Rate the Speakers - Kellyn Milani, N.D. Please select your answer 10 9 8 7 6 5 4 3 2 1
Specific speaker comments (Your additional input is appreciated)
4 out of 9
Immunology Updates “A to Z” ANDERSON Please select your answer 10 9 8 7 6 5 4 3 2 1
Immune Disruptors beyond Mycotoxins ANDERSON Please select your answer 10 9 8 7 6 5 4 3 2 1
Immune Suppressive Mechanism of Mold CRISTA Please select your answer 10 9 8 7 6 5 4 3 2 1
Mold & Mycotoxin Induced Endocrine Disruption TESSIER Please select your answer 10 9 8 7 6 5 4 3 2 1
Clinical and Laboratory Assessment of Non- mycotoxin Immune Disruptors ANDERSON Please select your answer 10 9 8 7 6 5 4 3 2 1
Immunomodulators Part-1: Therapies of Note ANDERSON Please select your answer 10 9 8 7 6 5 4 3 2 1
Immune Disruption: Strategies for Clinicians EXPERT PANEL DISCUSSION 1 Please select your answer 10 9 8 7 6 5 4 3 2 1
Specific topic comments (Your additional input is appreciated)
5 out of 9
Mycotoxin Assessment: The Good (and Not so Good...) CRISTA Please select your answer 10 9 8 7 6 5 4 3 2 1
Legal and Ethical Implications of Mold Related Diagnoses TESSIER Please select your answer 10 9 8 7 6 5 4 3 2 1
Mold Treatment Approach Part-1 & 2 CRISTA Please select your answer 10 9 8 7 6 5 4 3 2 1
Identity and Addressing Clinical Reactions in Mold Illness TESSIER Please select your answer 10 9 8 7 6 5 4 3 2 1
Mold & Mycotoxin Induced Fatigue TESSIER Please select your answer 10 9 8 7 6 5 4 3 2 1
Mold & Mycotoxin Illness in The Pediatric Population TESSIER Please select your answer 10 9 8 7 6 5 4 3 2 1
Mold/Mycotoxin Clinical Management EXPERT PANEL DISCUSSION 2 Please select your answer 10 9 8 7 6 5 4 3 2 1
Specific topic comments (Your additional input is appreciated)
6 out of 9
Neuropsychiatric effects of Mast Cell Activation, Related Conditions and NeuroQuant Imaging ACKERLEY Please select your answer 10 9 8 7 6 5 4 3 2 1
Chronic Inflammatory Response Syndrome (CIRS) Part-1 & 2 MILANI Please select your answer 10 9 8 7 6 5 4 3 2 1
Immunomodulators Part-2: Prescription and Management ANDERSON Please select your answer 10 9 8 7 6 5 4 3 2 1
Detoxification Therapies (Sauna, HBOT, NEUROFEEDBACK, Light, Liver/Kidney, Real Glutathione and Detox Nutrition, etc.) ANDERSON Please select your answer 10 9 8 7 6 5 4 3 2 1
Pharmacology: Anti-Fungal, Parasitic, Biofilm and other Rx Therapies ANDERSON Please select your answer 10 9 8 7 6 5 4 3 2 1
Immune Dysregulation Clinical Concepts EXPERT PANEL DISCUSSION 3 Please select your answer 10 9 8 7 6 5 4 3 2 1
Specific topic comments (Your additional input is appreciated)
7 out of 9
Event Organization (Did AAMP keep you updated with easy to follow information, before and during the conference?) Please select your answer 10 9 8 7 6 5 4 3 2 1
Problem Solving ( In this 2020 Virtual World, how well did AAMP address any issues you had during the conference?) Please select your answer 10 9 8 7 6 5 4 3 2 1
Virtual Lobby (How easy was it to navigate, from the “Stage” to the “Expo” to the “People”?) Please select your answer 10 9 8 7 6 5 4 3 2 1
Virtual Expo (For the most part, was the material presented useful and was your interaction with exhibitors helpful?) Please select your answer 10 9 8 7 6 5 4 3 2 1
Your Fellow Attendees (You had with the opportunity to chat with other attendees. How useful did you find it?) Please select your answer 10 9 8 7 6 5 4 3 2 1
Did you gain from the level of learning anticipated Please select your answer 10 9 8 7 6 5 4 3 2 1
Overall, was it a good mix of speakers Please select your answer 10 9 8 7 6 5 4 3 2 1
IF THIS WASN’T YOUR 1st VIRTUAL CONFERENCE, HOW DID IT RATE AGAINST OTHERS YOU’VE ATTENDED? Please select your answer 10 9 8 7 6 5 4 3 2 1
General comments (Your additional input is appreciated)
8 out of 9